Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes
- 1 February 2016
- journal article
- clinical trial
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 101 (2), 714-722
- https://doi.org/10.1210/jc.2015-3437
Abstract
Context: Roux-en-Y gastric bypass (RYGB) leads to high-turnover bone loss, but little is known about skeletal effects of laparoscopic adjustable gastric banding (LAGB) or mechanisms underlying bone loss after bariatric surgery. Objective: To evaluate effects of RYGB and LAGB on fasting and postprandial indices of bone remodeling. Design and Setting: Ancillary investigation of a prospective study at 2 academic institutions. Participants: Obese adults aged 21–65 years with type 2 diabetes who underwent RYGB (n = 11) or LAGB (n = 8). Outcomes: Serum C-terminal telopeptide (CTX), procollagen type 1 N-terminal propeptide (P1NP), and PTH were measured during a mixed meal tolerance test at baseline, 10 days and 1 year after surgery. Changes in 25-hydroxyvitamin D, polypeptide YY (PYY), glucagon-like peptide-1, glucose-dependent insulinotropic peptide, and insulin were also assessed. Results: Fasting CTX increased 10 days after RYGB but not LAGB (+69 ± 23% vs +12±12%, P < .001), despite comparable weight loss at that time. By 1 year, fasting CTX and P1NP increased more after RYGB than LAGB (CTX +221 ± 60% vs +15 ± 6%, PP < .001) and weight loss was greater with RYGB. Changes in CTX were independent of PTH and 25-hydroxyvitamin D but were associated with increases in fasting PYY. Postprandial suppression of CTX was more pronounced after RYGB than LAGB at 10 days and 1 year postoperatively. Conclusions: RYGB is accompanied by early increases in fasting indices of bone remodeling, independent of weight loss or changes in PTH or 25-hydroxyvitamin D. LAGB did not affect bone markers. PYY and other enterohormonal signals may play a role in RYGB-specific skeletal changes.Keywords
This publication has 43 references indexed in Scilit:
- Sclerostin Levels and Changes in Bone Metabolism After Bariatric SurgeryJournal of Clinical Endocrinology & Metabolism, 2015
- Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 DiabetesJAMA Surgery, 2014
- Bone Metabolism After Bariatric SurgeryJournal of Bone and Mineral Research, 2014
- Feeding and Bone Turnover in Gastric BypassJournal of Clinical Endocrinology & Metabolism, 2014
- Roux-en-Y Gastric Bypass Surgery But Not Vertical Sleeve Gastrectomy Decreases Bone Mass in Male RatsEndocrinology, 2013
- Type 2 diabetes and boneJournal of Bone and Mineral Research, 2012
- Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort studyBMJ, 2012
- Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trialSurgery for Obesity and Related Diseases, 2009
- Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone massBone, 2007
- Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fastingBone, 2002